BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16874467)

  • 1. Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats.
    Simola N; Tronci E; Pinna A; Morelli M
    Amino Acids; 2006 Nov; 31(4):359-63. PubMed ID: 16874467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release.
    Cauli O; Pinna A; Valentini V; Morelli M
    Neuropsychopharmacology; 2003 Oct; 28(10):1752-9. PubMed ID: 12865902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization to caffeine and cross-sensitization to amphetamine: influence of individual response to caffeine.
    Simola N; Cauli O; Morelli M
    Behav Brain Res; 2006 Sep; 172(1):72-9. PubMed ID: 16740323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.
    Tronci E; Simola N; Carta AR; De Luca MA; Morelli M
    J Neurochem; 2006 Aug; 98(4):1078-89. PubMed ID: 16771831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior treatment (priming) with caffeine sensitizes D2-dopamine-mediated contralateral rotational behavior in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Dimitrov KD; Drake JD
    Pharmacology; 2010; 86(2):73-8. PubMed ID: 20639686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonists.
    Cauli O; Pinna A; Morelli M
    Behav Pharmacol; 2005 Dec; 16(8):621-6. PubMed ID: 16286813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine induces differential cross tolerance to the amphetamine-like discriminative stimulus effects of dopaminergic agonists.
    Jain R; Holtzman SG
    Brain Res Bull; 2005 May; 65(5):415-21. PubMed ID: 15833596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effects.
    Simola N; Morelli M; Seeman P
    Synapse; 2008 May; 62(5):394-7. PubMed ID: 18297691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
    Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats.
    Sawynok J; Reid A
    J Pharmacol Exp Ther; 1996 May; 277(2):646-53. PubMed ID: 8627541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic effects of oxotremorine-M on turning behavior induced by caffeine in 6-OHDA-lesioned rats.
    Núñez-Taltavull JF; Prat G; Rubio A; Robledo P; Casas M
    Eur J Pharmacol; 2004 Dec; 506(1):71-4. PubMed ID: 15588626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD).
    Caballero M; Núñez F; Ahern S; Cuffí ML; Carbonell L; Sánchez S; Fernández-Dueñas V; Ciruela F
    Neurosci Lett; 2011 Apr; 494(1):44-8. PubMed ID: 21362462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the ambulatory activity and discriminative stimulus effects of psychostimulant drugs in rats chronically exposed to caffeine: effect of caffeine dose.
    Gasior M; Jaszyna M; Peters J; Goldberg SR
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1101-11. PubMed ID: 11082446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
    Srinivasan J; Schmidt WJ
    J Neural Transm (Vienna); 2005 Sep; 112(9):1223-36. PubMed ID: 15614426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of dopamine agonists on rotational behavior in non-tolerant and caffeine-tolerant rats.
    Garrett BE; Holtzman SG
    Behav Pharmacol; 1995 Dec; 6(8):843-851. PubMed ID: 11224389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal caffeine exposure: effects on motor skills and locomotor activity during ontogenesis.
    Tchekalarova J; Kubova H; Mares P
    Behav Brain Res; 2005 May; 160(1):99-106. PubMed ID: 15836904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal administration of N-omega-nitro-L-arginine induces permanent decrease in NO levels and hyperresponsiveness to locomotor activity by D-amphetamine in postpubertal rats.
    Morales-Medina JC; Mejorada A; Romero-Curiel A; Aguilar-Alonso P; León-Chávez BA; Gamboa C; Quirion R; Flores G
    Neuropharmacology; 2008 Dec; 55(8):1313-20. PubMed ID: 18790702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.